Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Increased risk for distant metastasis in patients with familial early-stage breast cancer and high EZH2 expression.

Breast cancer research and treatment - 1 Apr 2012

Alford Sharon Hensley, Toy Katherine, Merajver Sofia D, Kleer Celina G

Abstract excerpt

The identification of women with early-stage breast cancer who will develop distant metastasis may improve clinical management. The transcriptional regulator Enhancer of Zeste-2 (EZH2) is overexpressed in invasive breast carcinoma compared with benign breast tissues, with maximal expression in br...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma
Share to Enhancer of Zeste Homolog 2 Protein
Share to Heredity

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lymphatic Metastasis

Share to Michigan

Share to Polycomb Repressive Complex 2

Share to Proportional Hazards Models

Share to Tissue Array Analysis

Source

Open in PubMed Open full text

Identifiers

PMID: 21614565
DOI: 10.1007/s10549-011-1591-2
PMCID: PMC3311223

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-21614565-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Increased risk for distant metastasis in patients with familial early-stage breast cancer and high EZH2 expression.PMID 21614565Read ↗

EZH2 mutation is associated with the development of visceral metastasis by enhancing proliferation and invasion and inhibiting apoptosis in breast cancer cells.Semantic proximity Read ↗

Inhibition of EZH2 Catalytic Activity Selectively Targets a Metastatic Subpopulation in Triple-Negative Breast Cancer.Semantic proximity Read ↗

The Low Expression of MEOX2 is Associated With Poorer Survival in Breast CancerSemantic proximity Read ↗

Correlations of EZH2 and SMYD3 gene polymorphisms with breast cancer susceptibility and prognosis.Semantic proximity Read ↗

EZH2 knockdown suppresses the growth and invasion of human inflammatory breast cancer cellsSemantic proximity Read ↗

H3K27me3 mediated KRT14 upregulation promotes TNBC peritoneal metastasisSemantic proximity Read ↗

High BRCA1 Gene Expression Increases the Risk of Early Onset Distant Metastasis in ER+ Breast CancersSemantic proximity Read ↗

EZH2 overexpression in different immunophenotypes of breast carcinoma and association with clinicopathologic features.Semantic proximity Read ↗

EMSY and CCND1 amplification in familial breast cancer: from the Ontario site of the Breast Cancer Family Registry.Semantic proximity Read ↗

The epigenetic modifier EZH2 controls melanoma growth and metastasis through silencing of distinct tumour suppressors.Semantic proximity Read ↗

Global H3K27 trimethylation and EZH2 abundance in breast tumor subtypes.Semantic proximity Read ↗

Aberrant Epigenetic Regulation in Head and Neck Cancer Due to Distinct EZH2 Overexpression and DNA Hypermethylation<strong> </strong>Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.